Economy

AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) Moving Today - Down by 11.54%

The stock was purchased at an average cost of $3.00 per share, with a total value of $45,000.00. In the latest earnings report the EPS was $-1.10 and is expected to be $-1.12 for the current year with 45,380,000 shares presently outstanding. Johnson & Johnson now has $365.35B valuation.

The stock increased 0.40% or $0.03 during the last trading session, reaching $7.59. The Price Range 52 Weeks is one of the tools that investors use to determine the lowest and highest price at which a stock has traded in the previous 52 weeks. Johnson & Johnson (NYSE:JNJ) has risen 12.54% since October 17, 2016 and is uptrending. It has underperformed by 14.60% the S&P500.

Analysts recommendation for AcelRx Pharmaceuticals, Inc. The stock now has an average rating of "Hold" and a consensus target price of $7.67. Roth Capital has "Buy" rating and $12.5000 target. The stock has "Buy" rating by Seaport Global on Friday, May 6. TH Capital has "Buy" rating and $15 target.

AcelRx Pharmaceuticals, Inc. (ACRX) reported sales (ttm) of 15.6 Million, whereas, 6 number of analysts estimated the mean sale of 2.84 million. Royal Bank Of Canada now has an outperform rating on the stock. On Tuesday, May 3 the stock rating was maintained by H.C. Wainwright with "Buy". As per Monday, October 5, the company rating was maintained by TH Capital.

TRADEMARK VIOLATION WARNING: "AcelRx Pharmaceuticals' (NASDAQ:ACRX) Buy Rating Reaffirmed at HC Wainwright" was first published by TrueBlueTribune and is owned by of TrueBlueTribune. Acelrx Pharmaceutica (NASDAQ:ACRX) has trailing twelve month Return on Assets of -53.3%, which is key indicator of how profitable a company is relative to its total assets. Therefore 32% are positive. Zacks Investment Research raised AcelRx Pharmaceuticals from a sell rating to a hold rating in a research report on Friday, August 4th. As per Wednesday, September 20, the company rating was downgraded by Goldman Sachs. (NYSE:UPS) rating on Tuesday, December 13. The VC1 of AcelRx Pharmaceuticals, Inc. On Thursday, August 31 the stock rating was maintained by UBS with "Buy".

Not surprisingly, $1.70 is the stock's low for the year. The price to earnings ratio for AcelRx Pharmaceuticals, Inc. 148,309 are held by Lmr Limited Liability Partnership. 105 funds opened positions while 667 raised stakes.

Shares of Tesla, Inc. Salem Invest Counselors invested in 3,435 shares. 30,359 were accumulated by Guardian Investment Management. Fincl Bank Of America De invested in 14,964 shares. Bnp Paribas Arbitrage owns 8 shares. Hbk LP owns 49,349 shares.

Raffi Asadorian, CFO reported the purchase of 7,000 shares. Ing Groep Nv, Netherlands-based fund reported 39,000 shares. Horrell Mgmt owns 27,941 shares for 1.82% of their portfolio. Winslow Evans And Crocker stated it has 18,644 shares. Its down 13.86% from 4.66 million shares previously. Art Ltd Liability Corp holds 23,418 shares or 0% of its portfolio.

Brokerage houses, on average, are recommending investors to hold Tesla, Inc. Netapp Inc (NASDAQ:NTAP) was reduced too. Trading volume was up 1,651.63% over the stocks average daily volume. It is now trading 3.62% off that level. Creative Planning holds 0% in AcelRx Pharmaceuticals Inc (NASDAQ:ACRX) or 17,700 shares. It has underperformed by 30.94% the S&P500.

03/14/2017 - AcelRx Pharmaceuticals, Inc. had its "hold" rating reiterated by analysts at Stifel Nicolaus. This is helpful in determining how the market values the company compared to it's actual worth. Its product ARX-01 is focused on acute post-operative pain, ARX-02 is focused on the treatment of cancer breakthrough pain and ARX-03 is focused on providing mild sedation, anxiety reduction, and pain relief to patients undergoing painful procedures in a physician's office. It now has negative earnings. The Company operates through the segment, which includes development and commercialization of product candidates for the treatment of pain.

Investors sentiment increased to 1.05 in Q2 2017. Its down 0.25, from 1 in 2017Q1. Meeder Asset Incorporated holds 1,673 shares. Geode Cap Limited stated it has 175,262 shares or 0% of all its holdings. AcelRx Pharmaceuticals traded as low as $1.90 and last traded at $1.93, with a volume of 3,922,805 shares. Deutsche Fincl Bank Ag reported 293,770 shares stake. Da Davidson & Company reported 61,900 shares. In looking the SMA 200 we see that the stock has seen a -28.14%.The Company's net profit margin for the 12 months at -. Joel Isaacson & invested in 0.03% or 70,660 shares.

03/03/2017 - AcelRx Pharmaceuticals, Inc. had its "outperform" rating reiterated by analysts at RBC Capital. Manufacturers Life Ins Com The owns 2,077 shares for 0% of their portfolio.



Like this

loading...
loading...

Latest


18 October 2017
Met Office issue various weather warnings around the United Kingdom as Ophelia strikes
Several parts of Gwynedd and Anglesey have been hit with unusual sensations today thanks to the effects of ex-hurricane Ophelia . Southerly winds are most likely to gust between 55 and 65 miles per hour across much of the warning area, especially in the west.

18 October 2017
Abbott Laboratories (NYSE:ABT) Analytical Analysis
On average, equities analysts anticipate that Abbott Laboratories will post $2.49 earnings per share for the current fiscal year. Heading into the stock price potential, Abbott Laboratories needs to grow just 1.59% to cross its median price target of $55.5.

18 October 2017
1 on the Billboard charts
The song has performed especially well on streaming, a category that includes data from YouTube as well as services like Spotify. In the video's bio, there's a link that sends viewers to the streaming service of their choice to listen to the full song.

18 October 2017
Rui Vitoria backs Victor Lindelof to flourish at Manchester United
The Manchester United squad trained at the Estadio da Luz on Tuesday afternoon as preparations continued for the UEFA Champions League clash with Benfica .

18 October 2017
Verizon Communications Inc. (NYSE:VZ) Under Analyst Spotlight
COPYRIGHT VIOLATION NOTICE: This piece of content was originally posted by Week Herald and is the sole property of of Week Herald. Blackstone Group Lp sold 2.79 million shares as the company's stock declined 19.52% while stock markets rallied. (NYSE:VZ).

18 October 2017
Manchester United scout Aarón Martin as Mourinho wants a left-back
It's claimed the Spanish outfit are increasingly resigned to losing the Spain Under-21 defender in the January transfer window. And Red Devils scouts were in attendance as the youngster played in Friday's 0-0 draw with Levante , according to ESPN .

18 October 2017
JPMorgan Chase to acquire payments platform WePay
The deal would allow Chase to sign up small businesses more efficiently and let them get paid for credit-card purchases more quickly.

18 October 2017
Yankees leave Red Sox speechless with Twitter troll job
The Sox did manage to win the AL East, but they did so despite the fact that the Yankees were arguably the better team. But Roberts slid in ahead of the tag and Bill Mueller singled up the middle to to drive him in and tie the game.

18 October 2017
Rami Malek poses as Freddie Mercury in latest 'Bohemian Rhapsody' photo
Mercury, Brian May and Roger Taylor will all be portrayed in the film (obviously) and Malek will be doing much of his own singing. Bohemian Rhapsody will focus on Queen starting with the band's beginnings in 1970 up until the iconic 1985 Live Aid performance.

18 October 2017
Devendra Fadnavis stress on group farming
"We are in favour of the loan waiver, but the money required for the scheme can not be diverted from the SC and ST sub-plan". Also, 2.41 lakh applicants were declared ineligible for the waiver as they did not provide their Aadhaar details.